Xponance’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Buy
4,629
+64
+1% +$3.29K ﹤0.01% 1565
2026
Q1
$271K Buy
4,565
+647
+17% +$42K ﹤0.01% 1333
2025
Q4
$242K Buy
3,918
+31
+0.8% +$1.9K ﹤0.01% 1291
2025
Q3
$243K Buy
3,887
+26
+0.7% +$1.81K ﹤0.01% 1260
2025
Q2
$308K Buy
3,861
+95
+3% +$7.95K ﹤0.01% 1135
2025
Q1
$324K Buy
3,766
+196
+5% +$16.1K ﹤0.01% 1075
2024
Q4
$279K Buy
3,570
+328
+10% +$25.5K ﹤0.01% 1150
2024
Q3
$234K Buy
3,242
+100
+3% +$7.08K ﹤0.01% 1172
2024
Q2
$216K Buy
3,142
+114
+4% +$7.72K ﹤0.01% 1158
2024
Q1
$220K Buy
+3,028
New +$202K ﹤0.01% 1157
2021
Q1
Sell
-6,849
Closed -$239K 1052
2020
Q4
$239K Sell
6,849
-57
-0.8% -$2.02K 0.01% 1006
2020
Q3
$252K Sell
6,906
-80
-1% -$2.98K 0.01% 910
2020
Q2
$262K Buy
+6,986
New +$279K 0.01% 876

Other funds holding PBH

Xponance's PBH Position: Q2 2026 in Review

Xponance increased its Prestige Consumer Healthcare (PBH) stake by 1.4% in Q2 2026, buying an estimated $3.29K and bringing the position to 4,629 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #1565.

Xponance first reported a position in PBH in Q2 2020 and has held it in 13 quarters since. The position peaked at $324K in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Xponance held 4,629 shares of Prestige Consumer Healthcare worth $219K as of Q2 2026.
  • Xponance bought 64 Prestige Consumer Healthcare shares in Q2 2026, an estimated $3.29K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1565 holding.
  • Xponance first reported a position in Prestige Consumer Healthcare in Q2 2020 and has held it in 13 quarters since.
  • Xponance's Prestige Consumer Healthcare position peaked at $324K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.